1. Home
  2. SMTK vs XXII Comparison

SMTK vs XXII Comparison

Compare SMTK & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTK
  • XXII
  • Stock Information
  • Founded
  • SMTK 2009
  • XXII 1998
  • Country
  • SMTK United Kingdom
  • XXII United States
  • Employees
  • SMTK N/A
  • XXII N/A
  • Industry
  • SMTK
  • XXII Medicinal Chemicals and Botanical Products
  • Sector
  • SMTK
  • XXII Health Care
  • Exchange
  • SMTK NYSE
  • XXII Nasdaq
  • Market Cap
  • SMTK 6.1M
  • XXII 7.0M
  • IPO Year
  • SMTK N/A
  • XXII N/A
  • Fundamental
  • Price
  • SMTK $0.93
  • XXII $8.09
  • Analyst Decision
  • SMTK
  • XXII
  • Analyst Count
  • SMTK 0
  • XXII 0
  • Target Price
  • SMTK N/A
  • XXII N/A
  • AVG Volume (30 Days)
  • SMTK 150.8K
  • XXII 37.6K
  • Earning Date
  • SMTK 08-11-2025
  • XXII 08-12-2025
  • Dividend Yield
  • SMTK N/A
  • XXII N/A
  • EPS Growth
  • SMTK N/A
  • XXII N/A
  • EPS
  • SMTK N/A
  • XXII N/A
  • Revenue
  • SMTK $105,000.00
  • XXII $23,869,000.00
  • Revenue This Year
  • SMTK N/A
  • XXII $22.41
  • Revenue Next Year
  • SMTK N/A
  • XXII $76.35
  • P/E Ratio
  • SMTK N/A
  • XXII N/A
  • Revenue Growth
  • SMTK 854.54
  • XXII N/A
  • 52 Week Low
  • SMTK $0.78
  • XXII $6.28
  • 52 Week High
  • SMTK $7.80
  • XXII $2,837.04
  • Technical
  • Relative Strength Index (RSI)
  • SMTK N/A
  • XXII 24.50
  • Support Level
  • SMTK N/A
  • XXII $6.81
  • Resistance Level
  • SMTK N/A
  • XXII $9.50
  • Average True Range (ATR)
  • SMTK 0.00
  • XXII 1.70
  • MACD
  • SMTK 0.00
  • XXII -0.32
  • Stochastic Oscillator
  • SMTK 0.00
  • XXII 20.46

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: